Nilogen Oncosystems is led by a team of experienced and passionate individuals.
Our commitment to testing and customizing immuno-oncology drug development is proven and yields unparalleled results for our clients.

Sigrid M. Volko, Ph.D., CLP

President & CEO


Dr. Volko holds a Ph.D. in Biology from the University of Basel in Switzerland, and worked as a Research Fellow at the Harvard Medical School in Boston. She is an experienced business development professional and a Certified Licensing Professional with more than 14 years of experience in technology transfer at Massachusetts General Hospital in Boston and the Johns Hopkins University in Baltimore.

Soner Altiok, M.D., Ph.D.

Chief Scientific Officer


Dr. Altiok is a Professor of Pathology and Oncological Sciences at the Moffitt Cancer Center and the University of South Florida in Tampa. He holds an M.D. degree from the Medical School of Istanbul in Turkey and a Ph.D. degree in Molecular Cell Biology from the University of Basel in Switzerland. Dr. Altiok completed his postdoctoral training in Boston at the Dana Farber Cancer Institute and the Beth Israel Deaconess Medical Center, and pursued his clinical training in Pathology and Cytopathology at Massachusetts General Hospital, Harvard Medical School. Following his training, he became an Assistant Professor at the Johns Hopkins School of Medicine to continue his clinical and translational research efforts and joined the Moffitt Cancer Center in 2007. As a physician scientist, he has broad expertise in diagnostic pathology, tissue procurement and processing, preclinical cancer models, such as patient-derived ex vivo platforms and mouse xenograft models, as well as designing biomarker-driven clinical trials.

Mibel Pabón, Ph.D.



With more than 10 years of lab experience and broad expertise in designing and managing translational Immuno-oncology studies, Dr. Pabon serves as the Senior Scientist for Research and Development at Nilogen Oncosystems. Dr. Pabón holds a Ph.D. in Biomedical Sciences from the University of South Florida, and she pursued a post-doctoral fellowship in Immuno-oncology at the Moffitt Cancer Center in Tampa, Florida before joining Nilogen. 

be part of nilogen's dedicated team


Join Nilogen’s dedicated team of researchers working to decrease the costs of clinical trials and increase the outcomes for success to improve patient care.